Literature DB >> 9233413

Deep brain stimulation and thalamotomy for tremor compared.

R R Tasker1, M Munz, F S Junn, Z H Kiss, K Davis, J O Dostrovsky, A M Lozano.   

Abstract

Deep brain stimulation (DBS) and thalamotomy are both capable of abolishing tremor. However, no technique is perfect and if thalamotomy proves inadequate so that tremor recurs, presumably because of suboptimal lesion location, the only option is to repeat the thalamotomy. With DBS all that has been necessary to date is to change the parameters of stimulation. Similarly with complications such as the "cerebellar" ones and paraesthesiae. If these occur after thalamotomy one can only wait and hope that they will subside and they do not always do so. With DBS, changing the parameters in the authors' patients has so far been successful in eliminating them. DBS, like thalamotomy is very effective for controlling tremor in Parkinson's disease (PD) and essential tremor (ET) and for improving dexterity in ET, but both techniques are less useful for the control of dopa dyskinesia, Parkinsonian rigidity, or impaired dexterity in PD, though DBS may be better than thalamotomy for the latter condition. On the other hand, both DBS and thalamotomy are very effective in improving dexterity in PD and ET may depend upon the fact that in PD bradykinesia is a major component, whereas in ET only the tremor is. The advantages of DBS over thalamotomy have to be weighed against the peculiar risks of DBS and of course, its cost.

Entities:  

Mesh:

Year:  1997        PMID: 9233413     DOI: 10.1007/978-3-7091-6513-3_9

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  12 in total

Review 1.  Applications of electrical pacing in the body.

Authors:  Mervyn Deitel
Journal:  Obes Surg       Date:  2004-09       Impact factor: 4.129

2.  Parkinson's Disease: Surgical Options.

Authors:  Helen Bronte-Stewart
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

3.  Automated 3-dimensional brain atlas fitting to microelectrode recordings from deep brain stimulation surgeries.

Authors:  J Luis Luján; Angela M Noecker; Christopher R Butson; Scott E Cooper; Benjamin L Walter; Jerrold L Vitek; Cameron C McIntyre
Journal:  Stereotact Funct Neurosurg       Date:  2009-06-26       Impact factor: 1.875

Review 4.  Evolution of Movement Disorders Surgery Leading to Contemporary Focused Ultrasound Therapy for Tremor.

Authors:  Hena Ahmed; Wesley Field; Michael T Hayes; William Omar Contreras Lopez; Nathan McDannold; Srinivasan Mukundan; Travis S Tierney
Journal:  Magn Reson Imaging Clin N Am       Date:  2015-07-11       Impact factor: 2.266

Review 5.  Essential tremor: New advances.

Authors:  María Carolina Sepúlveda Soto; Alfonso Fasano
Journal:  Clin Park Relat Disord       Date:  2019-12-31

6.  Stereotactic radiosurgery for movement disorders.

Authors:  Leonardo Frighetto; Jorge Bizzi; Rafael D'Agostini Annes; Rodrigo Dos Santos Silva; Paulo Oppitz
Journal:  Surg Neurol Int       Date:  2012-01-14

7.  Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder.

Authors:  Garrett E Alexander
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

8.  Safety and long-term efficacy of ventro-oral thalamotomy for focal hand dystonia: A retrospective study of 171 patients.

Authors:  Shiro Horisawa; Taku Ochiai; Shinichi Goto; Takeshi Nakajima; Nobuhiko Takeda; Atsushi Fukui; Tomoko Hanada; Takakazu Kawamata; Takaomi Taira
Journal:  Neurology       Date:  2018-12-26       Impact factor: 9.910

9.  Clinical features, pathophysiology, and treatment of levodopa-induced dyskinesias in Parkinson's disease.

Authors:  J Guridi; R González-Redondo; J A Obeso
Journal:  Parkinsons Dis       Date:  2012-10-17

Review 10.  Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?

Authors:  Jean-François Daneault; Benoit Carignan; Abbas F Sadikot; Michel Panisset; Christian Duval
Journal:  BMC Med       Date:  2013-03-20       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.